Significance of Fas protein in squamous cell carcinoma of the larynx

Acta Oto-Laryngologica

Volumn 120, Issue 4, 2000, Pages 557-561

  Bayazit, Yildirim ^a   Mumbuç, Semih ^a   Uçak, Ramazan ^a   Kanlikama, Muzaffer ^a   Bakir, Kemal ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Fas; Laryngeal carcinoma

Indexed keywords

FAS ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; ANTIGENS, CD95; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS;

EID: 0034580472     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/000164800750046108     Document Type: Article

References (21)

1. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium
2. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
3. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
4. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy
5. Apoptosis in epithelial hyperplastic laryngeal lesions
6. Physician education: Apoptosis
7. Safety and antitumor activity of recombinant soluble Apo2 ligand
8. Expression of Fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: Immunohistochemical study
9. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid
10. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
11. The implications of proliferation and apoptosis for lung cancer metastasis
12. Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: Absence of prognostic correlations
13. Localization of Fas antigen in oral squamous cell carcinoma
14. Fas antigen expression in hepatocellular carcinoma tissues
15. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease
16. Expression of Fas/APO-1 during the progression of astrocytomas
17. Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage
18. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
19. Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas
20. Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma
21. Expression of nm23/NDP kinase and cancer metastasis